Bosulif Prices, Coupons, Copay Cards & Patient Assistance
Bosulif (bosutinib) is a member of the BCR-ABL tyrosine kinase inhibitors drug class and is commonly used for Chronic Myelogenous Leukemia.
A generic version of Bosulif has been approved by the FDA. However, we either do not have pricing information for it, or it is not commercially available. View generic Bosulif availability for more details.
Bosulif prices
Oral Capsule
50 mg Bosulif oral capsule from $5,423.68 for 30 capsules
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $180.79 | $5,423.68 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
100 mg Bosulif oral capsule from $27,091.41 for 150 capsules
| Quantity | Per unit | Price |
|---|---|---|
| 150 | $180.61 | $27,091.41 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Oral Tablet
100 mg Bosulif oral tablet from $21,674.73 for 120 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 120 | $180.62 | $21,674.73 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
400 mg Bosulif oral tablet from $21,674.73 for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $722.49 | $21,674.73 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
500 mg Bosulif oral tablet from $21,674.73 for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $722.49 | $21,674.73 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Bosulif Coupons, Copay Cards and Rebates
Bosulif offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Bosulif Pfizer Oncology Together Co-Pay Savings Program
Eligible commercially insured patients may pay $0 per prescription with savings of up to $25,000 per calendar year; for additional information contact the program at 877-744-5675.
- Applies to:
- Bosulif
- Number of uses:
- 12 times within calendar year
- Expires
- December 31, 2026
Form more information phone: 877-744-5675 or Visit website
Healthcare providers may order samples of Bosulif for their practice by clicking on the Order tab on the top of the webpage or by calling 800-666-7248.
- Applies to:
- Bosulif
- Number of uses:
- Per length of program
Form more information phone: 800-666-7248 or Visit website
Bosulif Pfizer Oncology Together Co-Pay Savings Program Rebate
Eligible commercially insured patients may submit a request for a rebate in connection with this offer if their pharmacy does not participate in the program; for additional information contact the program at 877-744-5675.
- Applies to:
- Bosulif
- Number of uses:
- One rebate per prescription fill
- Expires
- December 31, 2026
Form more information phone: 877-744-5675 or Visit website
Healthcare providers may obtain a free 30-day trial offer voucher of Bosulif for their patients who are just beginning treatment.
- Applies to:
- Bosulif
- Number of uses:
- One-time offer
- Expires
- December 31, 2025
Form more information phone: 877-744-5675 or Visit website
Bosulif Medicare Part D Extra Help Subsidy
Patients with Medicare Part D coverage may be eligible for the Extra Help Subsidy, which may lower premiums and prescription costs. Contact the program for more information.
- Applies to:
- Bosulif
- Number of uses:
- Per length of program
Form more information phone: 800-772-1213 or Visit website
Patient Assistance & Copay Programs for Bosulif
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Pfizer Patient Assistance Program
Eligibility requirements:- Uninsured or Underinsured
- Varies
- Not specified
- Must be residing in the US or US territory
- Pfizer also has programs that provide eligible patients with insurance, support assistance, and medicines at a savings. Contact Pfizer RxPathways for details (844-989-7284).
- Bosulif (bosutinib monohydrate)
More information please phone: 866-706-2400 Visit website
Provider: Pfizer Oncology Together
Eligibility requirements:- Contact program for details.
- At or below 300% of FPL
- FDA-approved diagnosis
- The patient must also be under treatment from a US doctor.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Bosulif (bosutinib) Capsule
- Bosulif (bosutinib monohydrate) Tablet
More information please phone: 877-744-5675 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Bosulif (bosutinib)
- Check interactions
- Compare alternatives
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español